Spirit Scientific Co., Ltd. (7790.TWO)
Taipei Exchange · TWD · Healthcare · Biotechnology
NT$43.90 (+0.00%) as of
Key statistics
- Market cap
- 875.94M
- P/E (TTM)
- 86.08
- EPS (TTM)
- 0.51
- Dividend yield
- 1.37%
- 52-week range
- 41.50 – 76.10
- Revenue (TTM)
- 252.4M
- Profit margin
- 3.37%
- Volume
- 5.00
About Spirit Scientific Co., Ltd.
Spirit Scientific Co., Ltd. engages in the production and sale of growth factor jelly-related products. The company offers Platelet Lyophilized Treatment (PLT), a high-concentration platelet therapy derived from autologous blood; PLT Hydraglow, a hydrogel lyophilization combined with a hyaluronic acid hydrating essence, serves as a post-treatment care system for damaged skin; PLTgel; and PLT-AE. It also provides lyophilized biomaterial testing and CDMO services; biomaterial-based raw material production services; and integrated packaging and design solutions. In addition, the company offers laboratory consulting; and business solutions and operational flaw services. The company was founded in 2015 and is based in Taipei, Taiwan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Taipei, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.